At-home Molecular Testing Market Outlook (2023 to 2033)

The at-home molecular testing market size is projected to be worth US$ 10.2 billion in 2023. The market is likely to surpass US$ 18.1 billion by 2033 at a CAGR of 5.9% during the forecast period. Increased infectious illnesses and an increase in the number of diabetes patients around the world are driving the market expansion. For instance, monkey pox and other infectious illnesses pose a severe threat to public health and economic development in all nations. Additionally, the need for early detection of various diseases and growing awareness of them are fueling market expansion.

The prospective growth of the at-home testing market was influenced by the population's growing awareness of home care testing.

Other Drivers Propelling the Demand for At-home Molecular Testing Market include:

  • Due to the rise in diabetes prevalence, there is an increasing requirement for the market for molecular testing. As of 2021, 537 million individuals worldwide or about 10% of all adults aged 20 to 79 were living with diabetes, according to the latest recent IDF data.
  • The production of the newest at-home testing tools and kits, as well as a growing understanding of the advantages offered by these services, are promoting market expansion.
  • At-home kits are simple to obtain and are readily available at pharmacies and online retailers. Additionally, these at-home testing tools are accessible over the counter. As a result, the kits' widespread availability is promoting market expansion.
  • The market for at-home testing kits or medical devices with improved healthcare services has grown as a result of an increase in R&D activity in the field of personalized self-assessment kits for the diagnosis of HIV illness

Challenges for Companies /Manufacturers in the At-home Molecular Testing Market:

  • At home molecular testing kits or devices have undoubtedly eased the process of confirming the persons concern. However, uncertainty about the accuracy of the result is a key challenges for larger adoption.
  • Other restraining factor for at-home molecular testing market is the complex and evolving regulatory landscape. Compliance with the regulations can be time-consuming and costly for companies, limiting their ability to bring new products to market.
  • Test menu for at home tests are relatively limited compared to traditional laboratory-based tests. Complex or specialized tests may still require a visit to a healthcare facility, limiting the market potential of at-home testing.

Opportunities in the At-home Molecular Testing Market Industry:

  • Rising demand for personalized medicine and the increasing focus on personalized medicine presents a significant opportunity for at-home molecular testing.
  • Advances in technology, such as improved sample collection methods, more sensitive and accurate molecular assays, and user-friendly testing kits, will enhance the overall user experience, making testing easier and more reliable.
  • The significant financial investments made in healthcare and life science research in emerging markets are crucial in modernizing the laboratory infrastructure in developing nations, which promotes the expanding use of molecular diagnostics.

Latest Trends in the At-home Molecular Testing Market:

  • At-home testing kits now cover a wide range of health conditions and concerns, including hormone levels, fertility, food sensitivities, STIs, cholesterol levels, vitamin deficiencies, and more. This diversification allows individuals to gain insights into various aspects of their health and well-being.
  • The demand for accessible and convenient testing options has surged, leading to the rapid development and availability of at-home testing kits.
  • Hormone testing has gained popularity in the at-home testing kits market, particularly among individuals interested in monitoring and optimizing their hormonal balance.
Attributes Details
At-home Molecular Testing Market Size (2023) US$ 10.2 billion
At-home Molecular Testing Market Projected Size (2033) US$ 18.1 billion
Value CAGR (2023 to 2033) 5.9%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2017 to 2022 At-home Molecular Testing Market Demand Outlook Compared to 2023 to 2033 Forecast

From 2017 to 2022, the global at-home molecular testing market experienced a CAGR of 5.4%, reaching a market size of US$ 10.2 billion in 2023.

From 2017 to 2022, the global at-home molecular testing market industry witnessed steady growth due to the increased awareness and acceptance of at-home molecular testing. The at-home molecular testing market was in its infancy, primarily focused on genetic testing for ancestry and genealogy purposes. Companies like 23andMe and AncestryDNA gained popularity, attracting consumers interested in exploring their genetic heritage. The market witnessed increased awareness and acceptance of at-home molecular testing during this period. More consumers recognized the potential benefits of understanding their genetic health risks and gaining personalized insights. The market diversified to include tests for traits, wellness, and lifestyle factors, such as diet and exercise recommendations based on genetic profiles.

Future Forecast for At-home Molecular Testing Market Industry:

Looking ahead, the global at-home molecular testing market industry is expected to rise at a CAGR of 5.9% from 2023 to 2033. During the forecast period, the market size is expected to reach US$ 18.1 billion by 2033.

The at-home molecular testing market industry is expected to continue its growth trajectory from 2023 to 2033. The at-home molecular testing market is expected to witness an expansion of the test menu, offering a wider range of genetic and molecular tests. As scientific knowledge expands, more disease markers, genetic variants, and actionable insights will be identified, leading to the development of new tests. This diversification will attract a larger consumer base and drive market growth.

The growing focus on personalized medicine and preventive healthcare will fuel the demand for at-home molecular testing. Individuals are increasingly interested in understanding their genetic predispositions, optimizing their health choices, and monitoring disease risks. At-home testing provides a convenient and accessible means to achieve these goals.

Comparative View of the At-home Molecular Testing Market

At-home Molecular Testing Market:

Attributes At-home Molecular Testing Market
CAGR (2023 to 2033) 5.9%
Market Value (2033) US$ 18.1 million
Opportunity Rising demand for personalized medicine and the increasing focus on personalized medicine presents a significant opportunity for at-home molecular testing.
Key Trends The demand for accessible and convenient testing options has surged, leading to the rapid development and availability of at-home testing kits

At-home Testing Market:

Attributes At-home Testing Market
CAGR (2023 to 2033) 4.0%
Market Value (2033) US$ 10.9 billion
Opportunity The market is set to present an opportunistic outlook, due to technological developments in sample collection and manufacturers efforts to develop easy to use disposable test kits.
Key Trends The expanding research and development of the at-home testing products, increased awareness about health and hygiene, HIV health awareness, immense advertising, and increasing number of infectious diseases, are the key trends of the market.

At-home vaginal pH Test Kit Market:

Attributes At-home vaginal pH Test Kit Market
CAGR (2023 to 2033) 5.4%
Market Value (2033) US$ 185.2 million
Opportunity Increasing vaginal infections as well as hygiene among the women in the globe.
Key Trends The growing practice of self-testing is expected to augment the at-home vaginal pH test kit market.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Country-Wise Insights

At-home Molecular Testing Market to Surge in the United States Due to Rising Prevalence of Diabetes.

Country The United States
Market Size (US$ billion) by End of Forecast Period (2033) US$ 5.6 billion
CAGR % 2023 to End of Forecast (2033) 7.2%

The at-home molecular testing market industry in the United States is expected to reach a market size of US$ 5.6 billion by 2033, expanding at a CAGR of 7.2%. Due to the rising demand for at home diabetic testing kits. In the United States, more than 130 million persons have diabetes or prediabetes, according to the Centers for Disease Control and Prevention 2022. Such growing prevalence of diabetes in the country, the demand for at home molecular testing market is high.

Rising Demand for At-home Molecular Testing Market is Due to the Growing Awareness Regarding Personalized Medicine.

Country The United Kingdom
Market Size (US$ billion) by End of Forecast Period (2033) US$ 689.1 million
CAGR % 2023 to End of Forecast (2033) 6.8%

The at-home molecular testing market industry in the United Kingdom is expected to reach a market share of US$ 689.1 million, expanding at a CAGR of 6.8% during the forecast period. The United Kingdom market is projected to growth of the market due to the growing personalized medicine initiatives. The United Kingdom has been at the forefront of personalized medicine initiatives, aiming to provide tailored healthcare based on an individual's genetic profile. At-home molecular testing plays a crucial role in these initiatives, allowing individuals to access genetic information, identify disease risks, and participate in research studies to advance personalized healthcare.

Notable Growth Expected in China's At-home Molecular Testing Market as Prevalence of Chronic Diseases in the Country.

Country China
Market Size (US$ billion) by End of Forecast Period (2033) US$ 1.30 billion
CAGR % 2023 to End of Forecast (2033) 5.1%

The at-home molecular testing market industry in China is anticipated to reach a market size of US$ 1.30 billion, moving at a CAGR of 5.1% during the forecast period. The at-home molecular testing market industry in China is expected to grow prominently due to the increasing chronic disease. China is facing a rising burden of chronic diseases, such as cardiovascular diseases, diabetes, and cancer. At-home molecular testing offers a way for individuals to monitor their health, detect diseases early, and take preventive measures. The ability to access testing from the comfort of their homes aligns with the increasing emphasis on preventive healthcare.

Growing Technological Advancement and E-commerce Development to Drive Market Growth in Japan

Country Japan
Market Size (US$ billion) by End of Forecast Period (2033) US$ 1.12 billion
CAGR % 2023 to End of Forecast (2033) 5.8%

The at-home molecular testing market industry in Japan is estimated to reach a market size of US$ 1.12 billion by 2033, thriving at a CAGR of 5.8%. The market in Japan is predicted to grow because of the growing technological advancements. Japan has a well-established e-commerce infrastructure and a high penetration of smartphones. This has facilitated the growth of online platforms and marketplaces for at-home molecular testing kits. The ease of purchasing and accessing these kits online has contributed to the rising demand in the country.

Demand for At-home Molecular Testing Market is Rising Due to Increasing Awareness and Acceptance of the Market.

Country South Korea
Market Size (US$ billion) by End of Forecast Period (2033) US$ 253.9 million
CAGR % 2023 to End of Forecast (2033) 3.6%

The at-home molecular testing market industry in South Korea is expected to reach a market size of US$ 253.9 million, expanding at a CAGR of 3.6% during the forecast period. The market in South Korea is forecasted to witness growth due to the increased awareness and acceptance. There has been a growing awareness and acceptance of at-home molecular testing among the general population in the South Korea. Consumers are increasingly interested in understanding their genetic heritage, health risks, and ancestry. This has contributed to the rising demand for at-home genetic testing kits.

Category-Wise Insights

Cassette Test Devices to Dominate At-home Molecular Testing Market Industry with 6.7% CAGR through 2033

The cassettes are expected to dominate the at-home molecular testing market industry with a CAGR of 6.7% from 2023 to 2033. This segment captures a significant market share in 2023 due to its rapid testing procedures, high efficiency, and improved testing kits.

According to the needs of the consumer, diagnostic cassettes for rapid test for diagnostic kits can be used in a single way or many ways (two or four ways). For immediate results, Plastic Cassettes for Rapid Test (Cassettes for Diagnostic Kits) are frequently utilized. For the best outcomes, it also guarantees improved buffer flow with the right pressure points through the strip.

How the Infectious Diseases are Driving At-home Molecular Testing Market?

Infectious diseases are expected to dominate the at-home molecular testing market industry with a CAGR of 6.7% from 2023 to 2033. This segment captures a significant market share in 2023 as incidences of infectious diseases in the globe is on the rise.

The prevalence of infectious diseases in developed and developing regions will have a beneficial impact on market growth. The increasing number of prescriptions for at-home infectious illness diagnostic tests is due to the diagnosis and management of such infections.

Which Sample Type is Widely Adopted the At-home Molecular Testing Market?

The blood sample segment is expected to dominate the at-home molecular testing market industry with a CAGR of 5.5% from 2023 to 2033 and is expected to hold market share of 42.4% in 2023. Blood testing are extremely common. They aid clinicians in the detection of certain diseases and ailments. They also aid in the evaluation of organ function and the effectiveness of treatments. One of the most popular blood tests is the complete blood count (CBC). It is frequently performed as part of a standard checkup. This test evaluates a variety of blood components, including red blood cells, white blood cells, and platelets.

Which Distribution Channel Is Widely Adopted In the Market?

The drug store in dominating the at home molecular testing market with the CAGR of 6.2%. The ease of availability of the testing kits without prescription in the drug store the adoption is high.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

How Key Players Stay Competitive in the At-home Molecular Testing Market Industry?

The at-home molecular testing sector is fiercely competitive, with many companies fighting for market dominance. To stay ahead of the competition in such a circumstance, essential players must employ smart techniques.

Key Strategies Used by the Participants

  • Product Development

To produce innovative goods that increase efficacy, dependability, and cost-effectiveness, businesses make significant investments in research and development. Product innovation enables companies to stand out from the competition while also meeting the shifting needs of their customers.

  • Strategic Alliances & Collaborations

Strategic alliances and partnerships with other businesses are regularly formed by major players in an industry to take advantage of each other's advantages and expand their market reach. Through such arrangements, businesses may also obtain access to new technologies and markets.

  • Expansion into Emerging Markets

The market for at-home molecular testing is rising quickly in developing nations like China and India. To boost their presence in these regions, major companies are expanding their distribution networks and building regional manufacturing sites.

  • Acquisitions and mergers

Key companies in the at-home molecular testing market routinely employ mergers and acquisitions to strengthen their market positions, broaden their product offerings, and enter new markets.

Key Players in the At-home Molecular Testing Market Industry

  • Abbott
  • ACON Laboratories, Inc.
  • Rapikit
  • Becton and Dickinson
  • Cardinal Health
  • B. Braun Melsungen AG
  • Piramal Enterprises Ltd.
  • Siemens Healthcare GmbH
  • Quidel Corporation
  • Bionime Corporation
  • SA Scientific
  • ARKRAY USA, Inc.
  • Nova Biomedical
  • AdvaCare Pharma
  • AccuBioTech Co., Ltd.
  • Atlas Medical UK
  • TaiDoc Technology Corporation
  • Drägerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd
  • Sensing Self
  • PTE. Ltd
  • Atomo Diagnostics
  • Mankind Pharma

Key Developments in the At-home Molecular Testing Market:

  • On 23rd April 2022, Prega News, a pregnancy test kit brand owned by Mankind Pharma, has introduced a brand-new and sophisticated pregnancy detection test kit for the Indian market.
  • 10th June, 2022, Mylab Discovery Solutions, a biotech startup, has entered the women's healthcare market with the release of the PregaScreen home pregnancy test kit.

Segmentation Analysis of the At-home Molecular Testing Market

By Product:

  • Cassettes
  • Strips
  • Test Panels
  • Dip Cards
  • Midstreams
  • Others

By Test Type:

  • Pregnancy Tests
  • HIV Tests
  • Diabetes
  • Infectious Diseases
  • Glucose Tests
  • Ovulation Predictor Tests
  • Drug Abuse Tests
  • Others

By Sample Type:

  • Urine
  • Blood
  • Saliva
  • Others

By Distribution Channel:

  • Retail Pharmacies
  • Drug Stores
  • Supermarkets/Hypermarkets
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East & Africa

Frequently Asked Questions

What is the At-home Molecular Testing market CAGR for 2033?

The at-home molecular testing market CAGR for 2033 is 5.9%.

Which is the Leading Region in the At-home Molecular Testing market?

The North America region is the leading region in the market.

What is the projected market value of the global At-home Molecular Testing market for 2033?

The projected market value of the market for 2033 is US$ 10.2 billion.

How Key Players are Developing the At-home Molecular Testing Market?

Key players are developing the market by developing innovative tests.

Which are the Major Countries in the At-home Molecular Testing Market?

China, India, the United States, Japan, and Germany are the major countries in this market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Value Added Insights

    4.1. Product Adoption / Usage Analysis

    4.2. Product Features/ USPs

    4.3. Technological Roadmap

    4.4. Recent Product Approvals/Launces

    4.5. Reimbursement Scenario

    4.6. Regulatory Landscape

    4.7. PESTEL Analysis

    4.8. Porter’s Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Expenditure Outlook

        5.1.3. Global Life Expectancy Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Key Player’s Historic Growth

        5.2.2. Increasing Cases of Infectious Diseases

        5.2.3. Favourable Government Regulations

        5.2.4. Rising Demand for At Home Kits

        5.2.5. Technological Advancement in the Devices

        5.2.6. Increasing Prevalence of Diabetes

        5.2.7. Growing Product Demand For Genetic Predispositions

        5.2.8. Increasing Product Approvals/Launches

    5.3. Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. Global Market Volume (in Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033

    6.1. Historical Volume (in Units) Analysis, 2017 to 2022

    6.2. Current and Future Volume (in Units) Projections, 2023 to 2033

        6.2.1. Y-o-Y Growth Trend Analysis

7. Global Market - Pricing Analysis

    7.1. Regional Pricing Analysis By Product

    7.2. Pricing Break-up

        7.2.1. Manufacturer Level Pricing

        7.2.2. Distributor Level Pricing

    7.3. Global Average Pricing Analysis Benchmark

    7.4. Pricing Assumptions

8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2017 to 2022 and Forecast, 2023 to 2033

    8.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022

    8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2017 to 2022

    9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033

        9.3.1. Cassettes

        9.3.2. Strips

        9.3.3. Test Panels

        9.3.4. Dip Cards

        9.3.5. Midstreams

        9.3.6. Others

    9.4. Market Attractiveness Analysis By Product

10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Test Type

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Million) Analysis By Test Type, 2017 to 2022

    10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Test Type, 2023 to 2033

        10.3.1. Pregnancy Tests

        10.3.2. HIV Tests

        10.3.3. Diabetes

        10.3.4. Infectious Diseases

        10.3.5. Glucose Tests

        10.3.6. Ovulation Predictor Tests

        10.3.7. Drug Abuse Tests

        10.3.8. Others

    10.4. Market Attractiveness Analysis By Test Type

11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Sample Type

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Million) Analysis By Sample Type, 2017 to 2022

    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Sample Type, 2023 to 2033

        11.3.1. Urine

        11.3.2. Blood

        11.3.3. Saliva

        11.3.4. Others

    11.4. Market Attractiveness Analysis By Sample Type

12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Distribution Channel

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Million) Analysis By Distribution Channel, 2017 to 2022

    12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033

        12.3.1. Retail Pharmacies

        12.3.2. Drug Stores

        12.3.3. Supermarkets/Hypermarkets

        12.3.4. Online Pharmacies

    12.4. Market Attractiveness Analysis By Distribution Channel

13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Million) Analysis By Region, 2017 to 2022

    13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. South Asia

        13.3.5. East Asia

        13.3.6. Oceania

        13.3.7. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    14.1. Introduction

    14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        14.3.1. By Country

            14.3.1.1. USA

            14.3.1.2. Canada

        14.3.2. By Product

        14.3.3. By Test Type

        14.3.4. By Sample Type

        14.3.5. By Distribution Channel

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Product

        14.4.3. By Test Type

        14.4.4. By Sample Type

        14.4.5. By Distribution Channel

    14.5. Country Level Analysis & Forecast

        14.5.1. USA Market Analysis

            14.5.1.1. Introduction

            14.5.1.2. Market Analysis and Forecast by Market Taxonomy

                14.5.1.2.1. By Product

                14.5.1.2.2. By Test Type

                14.5.1.2.3. By Sample Type

                14.5.1.2.4. By Distribution Channel

        14.5.2. Canada Market Analysis

            14.5.2.1. Introduction

            14.5.2.2. Market Analysis and Forecast by Market Taxonomy

                14.5.2.2.1. By Product

                14.5.2.2.2. By Test Type

                14.5.2.2.3. By Sample Type

                14.5.2.2.4. By Distribution Channel

    14.6. Market Trends

    14.7. Key Market Participants - Intensity Mapping

    14.8. Drivers and Restraints - Impact Analysis

15. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    15.1. Introduction

    15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        15.3.1. By Country

            15.3.1.1. Brazil

            15.3.1.2. Mexico

            15.3.1.3. Argentina

            15.3.1.4. Rest of Latin America

        15.3.2. By Product

        15.3.3. By Test Type

        15.3.4. By Sample Type

        15.3.5. By Distribution Channel

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Product

        15.4.3. By Test Type

        15.4.4. By Sample Type

        15.4.5. By Distribution Channel

    15.5. Country Level Analysis & Forecast

        15.5.1. Brazil Market Analysis

            15.5.1.1. Introduction

            15.5.1.2. Market Analysis and Forecast by Market Taxonomy

                15.5.1.2.1. By Product

                15.5.1.2.2. By Test Type

                15.5.1.2.3. By Sample Type

                15.5.1.2.4. By Distribution Channel

        15.5.2. Mexico Market Analysis

            15.5.2.1. Introduction

            15.5.2.2. Market Analysis and Forecast by Market Taxonomy

                15.5.2.2.1. By Product

                15.5.2.2.2. By Test Type

                15.5.2.2.3. By Sample Type

                15.5.2.2.4. By Distribution Channel

        15.5.3. Argentina Market Analysis

            15.5.3.1. Introduction

            15.5.3.2. Market Analysis and Forecast by Market Taxonomy

                15.5.3.2.1. By Product

                15.5.3.2.2. By Test Type

                15.5.3.2.3. By Sample Type

                15.5.3.2.4. By Distribution Channel

    15.6. Market Trends

    15.7. Key Market Participants - Intensity Mapping

    15.8. Drivers and Restraints - Impact Analysis

16. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    16.1. Introduction

    16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        16.3.1. By Country

            16.3.1.1. Germany

            16.3.1.2. France

            16.3.1.3. Italy

            16.3.1.4. UK

            16.3.1.5. Spain

            16.3.1.6. Russia

            16.3.1.7. BENELUX

            16.3.1.8. Rest of Europe

        16.3.2. By Product

        16.3.3. By Test Type

        16.3.4. By Sample Type

        16.3.5. By Distribution Channel

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Product

        16.4.3. By Test Type

        16.4.4. By Sample Type

        16.4.5. By Distribution Channel

    16.5. Country Level Analysis & Forecast

        16.5.1. Germany Market Analysis

            16.5.1.1. Introduction

            16.5.1.2. Market Analysis and Forecast by Market Taxonomy

                16.5.1.2.1. By Product

                16.5.1.2.2. By Test Type

                16.5.1.2.3. By Sample Type

                16.5.1.2.4. By Distribution Channel

        16.5.2. France Market Analysis

            16.5.2.1. Introduction

            16.5.2.2. Market Analysis and Forecast by Market Taxonomy

                16.5.2.2.1. By Product

                16.5.2.2.2. By Test Type

                16.5.2.2.3. By Sample Type

                16.5.2.2.4. By Distribution Channel

        16.5.3. Italy Market Analysis

            16.5.3.1. Introduction

            16.5.3.2. Market Analysis and Forecast by Market Taxonomy

                16.5.3.2.1. By Product

                16.5.3.2.2. By Test Type

                16.5.3.2.3. By Sample Type

                16.5.3.2.4. By Distribution Channel

        16.5.4. UK Market Analysis

            16.5.4.1. Introduction

            16.5.4.2. Market Analysis and Forecast by Market Taxonomy

                16.5.4.2.1. By Product

                16.5.4.2.2. By Test Type

                16.5.4.2.3. By Sample Type

                16.5.4.2.4. By Distribution Channel

        16.5.5. Spain Market Analysis

            16.5.5.1. Introduction

            16.5.5.2. Market Analysis and Forecast by Market Taxonomy

                16.5.5.2.1. By Product

                16.5.5.2.2. By Test Type

                16.5.5.2.3. By Sample Type

                16.5.5.2.4. By Distribution Channel

        16.5.6. Russia Market Analysis

            16.5.6.1. Introduction

            16.5.6.2. Market Analysis and Forecast by Market Taxonomy

                16.5.6.2.1. By Product

                16.5.6.2.2. By Test Type

                16.5.6.2.3. By Sample Type

                16.5.6.2.4. By Distribution Channel

        16.5.7. BENELUX Market Analysis

            16.5.7.1. Introduction

            16.5.7.2. Market Analysis and Forecast by Market Taxonomy

                16.5.7.2.1. By Product

                16.5.7.2.2. By Test Type

                16.5.7.2.3. By Sample Type

                16.5.7.2.4. By Distribution Channel

    16.6. Market Trends

    16.7. Key Market Participants - Intensity Mapping

    16.8. Drivers and Restraints - Impact Analysis

17. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    17.1. Introduction

    17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        17.3.1. By Country

            17.3.1.1. India

            17.3.1.2. Thailand

            17.3.1.3. Indonesia

            17.3.1.4. Malaysia

            17.3.1.5. Rest of South Asia

        17.3.2. By Product

        17.3.3. By Test Type

        17.3.4. By Sample Type

        17.3.5. By Distribution Channel

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Product

        17.4.3. By Test Type

        17.4.4. By Sample Type

        17.4.5. By Distribution Channel

    17.5. Country Level Analysis & Forecast

        17.5.1. India Market Analysis

            17.5.1.1. Introduction

            17.5.1.2. Market Analysis and Forecast by Market Taxonomy

                17.5.1.2.1. By Product

                17.5.1.2.2. By Test Type

                17.5.1.2.3. By Sample Type

                17.5.1.2.4. By Distribution Channel

        17.5.2. Thailand Market Analysis

            17.5.2.1. Introduction

            17.5.2.2. Market Analysis and Forecast by Market Taxonomy

                17.5.2.2.1. By Product

                17.5.2.2.2. By Test Type

                17.5.2.2.3. By Sample Type

                17.5.2.2.4. By Distribution Channel

        17.5.3. Indonesia Market Analysis

            17.5.3.1. Introduction

            17.5.3.2. Market Analysis and Forecast by Market Taxonomy

                17.5.3.2.1. By Product

                17.5.3.2.2. By Test Type

                17.5.3.2.3. By Sample Type

                17.5.3.2.4. By Distribution Channel

        17.5.4. Malaysia Market Analysis

            17.5.4.1. Introduction

            17.5.4.2. Market Analysis and Forecast by Market Taxonomy

                17.5.4.2.1. By Product

                17.5.4.2.2. By Test Type

                17.5.4.2.3. By Sample Type

                17.5.4.2.4. By Distribution Channel

    17.6. Market Trends

    17.7. Key Market Participants - Intensity Mapping

    17.8. Drivers and Restraints - Impact Analysis

18. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    18.1. Introduction

    18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        18.3.1. By Country

            18.3.1.1. China

            18.3.1.2. Japan

            18.3.1.3. South Korea

        18.3.2. By Product

        18.3.3. By Test Type

        18.3.4. By Sample Type

        18.3.5. By Distribution Channel

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Product

        18.4.3. By Test Type

        18.4.4. By Sample Type

        18.4.5. By Distribution Channel

    18.5. Country Level Analysis & Forecast

        18.5.1. China Market Analysis

            18.5.1.1. Introduction

            18.5.1.2. Market Analysis and Forecast by Market Taxonomy

                18.5.1.2.1. By Product

                18.5.1.2.2. By Test Type

                18.5.1.2.3. By Sample Type

                18.5.1.2.4. By Distribution Channel

        18.5.2. Japan Market Analysis

            18.5.2.1. Introduction

            18.5.2.2. Market Analysis and Forecast by Market Taxonomy

                18.5.2.2.1. By Product

                18.5.2.2.2. By Test Type

                18.5.2.2.3. By Sample Type

                18.5.2.2.4. By Distribution Channel

        18.5.3. South Korea Market Analysis

            18.5.3.1. Introduction

            18.5.3.2. Market Analysis and Forecast by Market Taxonomy

                18.5.3.2.1. By Product

                18.5.3.2.2. By Test Type

                18.5.3.2.3. By Sample Type

                18.5.3.2.4. By Distribution Channel

    18.6. Market Trends

    18.7. Key Market Participants - Intensity Mapping

    18.8. Drivers and Restraints - Impact Analysis

19. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    19.1. Introduction

    19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        19.3.1. By Country

            19.3.1.1. Australia

            19.3.1.2. New Zealand

        19.3.2. By Product

        19.3.3. By Test Type

        19.3.4. By Sample Type

        19.3.5. By Distribution Channel

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Product

        19.4.3. By Test Type

        19.4.4. By Sample Type

        19.4.5. By Distribution Channel

    19.5. Country Level Analysis & Forecast

        19.5.1. Australia Market Analysis

            19.5.1.1. Introduction

            19.5.1.2. Market Analysis and Forecast by Market Taxonomy

                19.5.1.2.1. By Product

                19.5.1.2.2. By Test Type

                19.5.1.2.3. By Sample Type

                19.5.1.2.4. By Distribution Channel

        19.5.2. New Zealand Market Analysis

            19.5.2.1. Introduction

            19.5.2.2. Market Analysis and Forecast by Market Taxonomy

                19.5.2.2.1. By Product

                19.5.2.2.2. By Test Type

                19.5.2.2.3. By Sample Type

                19.5.2.2.4. By Distribution Channel

    19.6. Market Trends

    19.7. Key Market Participants - Intensity Mapping

    19.8. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    20.1. Introduction

    20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        20.3.1. By Country

            20.3.1.1. GCC Countries

            20.3.1.2. Türkiye

            20.3.1.3. Northern Africa

            20.3.1.4. South Africa

            20.3.1.5. Rest of Middle East and Africa

        20.3.2. By Product

        20.3.3. By Test Type

        20.3.4. By Sample Type

        20.3.5. By Distribution Channel

    20.4. Market Attractiveness Analysis

        20.4.1. By Country

        20.4.2. By Product

        20.4.3. By Test Type

        20.4.4. By Sample Type

        20.4.5. By Distribution Channel

    20.5. Country Level Analysis & Forecast

        20.5.1. GCC Countries Market Analysis

            20.5.1.1. Introduction

            20.5.1.2. Market Analysis and Forecast by Market Taxonomy

                20.5.1.2.1. By Product

                20.5.1.2.2. By Test Type

                20.5.1.2.3. By Sample Type

                20.5.1.2.4. By Distribution Channel

        20.5.2. Türkiye Market Analysis

            20.5.2.1. Introduction

            20.5.2.2. Market Analysis and Forecast by Market Taxonomy

                20.5.2.2.1. By Product

                20.5.2.2.2. By Test Type

                20.5.2.2.3. By Sample Type

                20.5.2.2.4. By Distribution Channel

        20.5.3. Northern Africa Market Analysis

            20.5.3.1. Introduction

            20.5.3.2. Market Analysis and Forecast by Market Taxonomy

                20.5.3.2.1. By Product

                20.5.3.2.2. By Test Type

                20.5.3.2.3. By Sample Type

                20.5.3.2.4. By Distribution Channel

        20.5.4. South Africa Market Analysis

            20.5.4.1. Introduction

            20.5.4.2. Market Analysis and Forecast by Market Taxonomy

                20.5.4.2.1. By Product

                20.5.4.2.2. By Test Type

                20.5.4.2.3. By Sample Type

                20.5.4.2.4. By Distribution Channel

    20.6. Market Trends

    20.7. Key Market Participants - Intensity Mapping

    20.8. Drivers and Restraints - Impact Analysis

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies

    21.2. Market Share Analysis of Top Players

    21.3. Market Presence Analysis

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Branding and Promotional Strategies, By Key Players

    22.3. Key Development Analysis

    22.4. Competition Deep Dive

        22.4.1. Abbott

            22.4.1.1. Overview

            22.4.1.2. Product Portfolio

            22.4.1.3. Key Financials

            22.4.1.4. Sales Footprint

            22.4.1.5. SWOT Analysis

            22.4.1.6. Strategy Overview

                22.4.1.6.1. Marketing Strategy

                22.4.1.6.2. Product Strategy

                22.4.1.6.3. Channel Strategy

        22.4.2. Rapikit

            22.4.2.1. Overview

            22.4.2.2. Product Portfolio

            22.4.2.3. Key Financials

            22.4.2.4. Sales Footprint

            22.4.2.5. SWOT Analysis

            22.4.2.6. Strategy Overview

                22.4.2.6.1. Marketing Strategy

                22.4.2.6.2. Product Strategy

                22.4.2.6.3. Channel Strategy

        22.4.3. Becton and Dickinson

            22.4.3.1. Overview

            22.4.3.2. Product Portfolio

            22.4.3.3. Key Financials

            22.4.3.4. Sales Footprint

            22.4.3.5. SWOT Analysis

            22.4.3.6. Strategy Overview

                22.4.3.6.1. Marketing Strategy

                22.4.3.6.2. Product Strategy

                22.4.3.6.3. Channel Strategy

        22.4.4. Cardinal Health

            22.4.4.1. Overview

            22.4.4.2. Product Portfolio

            22.4.4.3. Key Financials

            22.4.4.4. Sales Footprint

            22.4.4.5. SWOT Analysis

            22.4.4.6. Strategy Overview

                22.4.4.6.1. Marketing Strategy

                22.4.4.6.2. Product Strategy

                22.4.4.6.3. Channel Strategy

        22.4.5. B. Braun Melsungen AG

            22.4.5.1. Overview

            22.4.5.2. Product Portfolio

            22.4.5.3. Key Financials

            22.4.5.4. Sales Footprint

            22.4.5.5. SWOT Analysis

            22.4.5.6. Strategy Overview

                22.4.5.6.1. Marketing Strategy

                22.4.5.6.2. Product Strategy

                22.4.5.6.3. Channel Strategy

        22.4.6. Piramal Enterprises Ltd.

            22.4.6.1. Overview

            22.4.6.2. Product Portfolio

            22.4.6.3. Key Financials

            22.4.6.4. Sales Footprint

            22.4.6.5. SWOT Analysis

            22.4.6.6. Strategy Overview

                22.4.6.6.1. Marketing Strategy

                22.4.6.6.2. Product Strategy

                22.4.6.6.3. Channel Strategy

        22.4.7. Siemens Healthcare GmbH

            22.4.7.1. Overview

            22.4.7.2. Product Portfolio

            22.4.7.3. Key Financials

            22.4.7.4. Sales Footprint

            22.4.7.5. SWOT Analysis

            22.4.7.6. Strategy Overview

                22.4.7.6.1. Marketing Strategy

                22.4.7.6.2. Product Strategy

                22.4.7.6.3. Channel Strategy

        22.4.8. Quidel Corporation

            22.4.8.1. Overview

            22.4.8.2. Product Portfolio

            22.4.8.3. Key Financials

            22.4.8.4. Sales Footprint

            22.4.8.5. SWOT Analysis

            22.4.8.6. Strategy Overview

                22.4.8.6.1. Marketing Strategy

                22.4.8.6.2. Product Strategy

                22.4.8.6.3. Channel Strategy

        22.4.9. Bionime Corporation

            22.4.9.1. Overview

            22.4.9.2. Product Portfolio

            22.4.9.3. Key Financials

            22.4.9.4. Sales Footprint

            22.4.9.5. SWOT Analysis

            22.4.9.6. Strategy Overview

                22.4.9.6.1. Marketing Strategy

                22.4.9.6.2. Product Strategy

                22.4.9.6.3. Channel Strategy

        22.4.10. SA Scientific

            22.4.10.1. Overview

            22.4.10.2. Product Portfolio

            22.4.10.3. Key Financials

            22.4.10.4. Sales Footprint

            22.4.10.5. SWOT Analysis

            22.4.10.6. Strategy Overview

                22.4.10.6.1. Marketing Strategy

                22.4.10.6.2. Product Strategy

                22.4.10.6.3. Channel Strategy

        22.4.11. ARKRAY USA, Inc.

            22.4.11.1. Overview

            22.4.11.2. Product Portfolio

            22.4.11.3. Key Financials

            22.4.11.4. Sales Footprint

            22.4.11.5. SWOT Analysis

            22.4.11.6. Strategy Overview

                22.4.11.6.1. Marketing Strategy

                22.4.11.6.2. Product Strategy

                22.4.11.6.3. Channel Strategy

        22.4.12. Nova Biomedical

            22.4.12.1. Overview

            22.4.12.2. Product Portfolio

            22.4.12.3. Key Financials

            22.4.12.4. Sales Footprint

            22.4.12.5. SWOT Analysis

            22.4.12.6. Strategy Overview

                22.4.12.6.1. Marketing Strategy

                22.4.12.6.2. Product Strategy

                22.4.12.6.3. Channel Strategy

        22.4.13. AdvaCare Pharma

            22.4.13.1. Overview

            22.4.13.2. Product Portfolio

            22.4.13.3. Key Financials

            22.4.13.4. Sales Footprint

            22.4.13.5. SWOT Analysis

            22.4.13.6. Strategy Overview

                22.4.13.6.1. Marketing Strategy

                22.4.13.6.2. Product Strategy

                22.4.13.6.3. Channel Strategy

        22.4.14. AccuBioTech Co., Ltd.

            22.4.14.1. Overview

            22.4.14.2. Product Portfolio

            22.4.14.3. Key Financials

            22.4.14.4. Sales Footprint

            22.4.14.5. SWOT Analysis

            22.4.14.6. Strategy Overview

                22.4.14.6.1. Marketing Strategy

                22.4.14.6.2. Product Strategy

                22.4.14.6.3. Channel Strategy

        22.4.15. Atlas Medical UK

            22.4.15.1. Overview

            22.4.15.2. Product Portfolio

            22.4.15.3. Key Financials

            22.4.15.4. Sales Footprint

            22.4.15.5. SWOT Analysis

            22.4.15.6. Strategy Overview

                22.4.15.6.1. Marketing Strategy

                22.4.15.6.2. Product Strategy

                22.4.15.6.3. Channel Strategy

        22.4.16. TaiDoc Technology Corporation

            22.4.16.1. Overview

            22.4.16.2. Product Portfolio

            22.4.16.3. Key Financials

            22.4.16.4. Sales Footprint

            22.4.16.5. SWOT Analysis

            22.4.16.6. Strategy Overview

                22.4.16.6.1. Marketing Strategy

                22.4.16.6.2. Product Strategy

                22.4.16.6.3. Channel Strategy

        22.4.17. Drägerwerk AG & Co. KGaA

            22.4.17.1. Overview

            22.4.17.2. Product Portfolio

            22.4.17.3. Key Financials

            22.4.17.4. Sales Footprint

            22.4.17.5. SWOT Analysis

            22.4.17.6. Strategy Overview

                22.4.17.6.1. Marketing Strategy

                22.4.17.6.2. Product Strategy

                22.4.17.6.3. Channel Strategy

        22.4.18. F. Hoffmann-La Roche Ltd

            22.4.18.1. Overview

            22.4.18.2. Product Portfolio

            22.4.18.3. Key Financials

            22.4.18.4. Sales Footprint

            22.4.18.5. SWOT Analysis

            22.4.18.6. Strategy Overview

                22.4.18.6.1. Marketing Strategy

                22.4.18.6.2. Product Strategy

                22.4.18.6.3. Channel Strategy

        22.4.19. Sensing Self

            22.4.19.1. Overview

            22.4.19.2. Product Portfolio

            22.4.19.3. Key Financials

            22.4.19.4. Sales Footprint

            22.4.19.5. SWOT Analysis

            22.4.19.6. Strategy Overview

                22.4.19.6.1. Marketing Strategy

                22.4.19.6.2. Product Strategy

                22.4.19.6.3. Channel Strategy

        22.4.20. PTE. Ltd

            22.4.20.1. Overview

            22.4.20.2. Product Portfolio

            22.4.20.3. Key Financials

            22.4.20.4. Sales Footprint

            22.4.20.5. SWOT Analysis

            22.4.20.6. Strategy Overview

                22.4.20.6.1. Marketing Strategy

                22.4.20.6.2. Product Strategy

                22.4.20.6.3. Channel Strategy

        22.4.21. Atomo Diagnostics

            22.4.21.1. Overview

            22.4.21.2. Product Portfolio

            22.4.21.3. Key Financials

            22.4.21.4. Sales Footprint

            22.4.21.5. SWOT Analysis

            22.4.21.6. Strategy Overview

                22.4.21.6.1. Marketing Strategy

                22.4.21.6.2. Product Strategy

                22.4.21.6.3. Channel Strategy

        22.4.22. Mankind Pharma

            22.4.22.1. Overview

            22.4.22.2. Product Portfolio

            22.4.22.3. Key Financials

            22.4.22.4. Sales Footprint

            22.4.22.5. SWOT Analysis

            22.4.22.6. Strategy Overview

                22.4.22.6.1. Marketing Strategy

                22.4.22.6.2. Product Strategy

                22.4.22.6.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

Explore Healthcare Insights

View Reports
Future Market Insights

At-home Molecular Testing Market